156 related articles for article (PubMed ID: 29802692)
21. Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101).
Matsusaka S; Nashimoto A; Nishikawa K; Miki A; Miwa H; Yamaguchi K; Yoshikawa T; Ochiai A; Morita S; Sano T; Kodera Y; Kakeji Y; Sakamoto J; Saji S; Yoshida K
Gastric Cancer; 2016 Jul; 19(3):839-51. PubMed ID: 26265390
[TBL] [Abstract][Full Text] [Related]
22. Prognostic impact of CD44-positive cancer stem-like cells at the invasive front of gastric cancer.
Kodama H; Murata S; Ishida M; Yamamoto H; Yamaguchi T; Kaida S; Miyake T; Takebayashi K; Kushima R; Tani M
Br J Cancer; 2017 Jan; 116(2):186-194. PubMed ID: 27931044
[TBL] [Abstract][Full Text] [Related]
23. [Association of CD44 polymorphisms with genetic susceptibilities and clinico-pathologic characteristics in breast cancer].
Zhou X; Wu CY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Nov; 43(6):807-11. PubMed ID: 23387202
[TBL] [Abstract][Full Text] [Related]
24. FAM46C Serves as a Predictor of Hepatic Recurrence in Patients with Resectable Gastric Cancer.
Tanaka H; Kanda M; Shimizu D; Tanaka C; Kobayashi D; Hayashi M; Iwata N; Yamada S; Fujii T; Nakayama G; Sugimoto H; Fujiwara M; Niwa Y; Kodera Y
Ann Surg Oncol; 2017 Oct; 24(11):3438-3445. PubMed ID: 27770343
[TBL] [Abstract][Full Text] [Related]
25. Polymorphisms of cancer stem cell marker gene CD133 are associated with susceptibility and prognosis of gastric cancer.
Jia ZF; Wu YH; Cao DH; Cao XY; Jiang J; Zhou BS
Future Oncol; 2017 May; 13(11):979-989. PubMed ID: 28326835
[TBL] [Abstract][Full Text] [Related]
26. De-novo expression of CD44 and survival in gastric cancer.
Mayer B; Jauch KW; Günthert U; Figdor CG; Schildberg FW; Funke I; Johnson JP
Lancet; 1993 Oct; 342(8878):1019-22. PubMed ID: 7692200
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy.
Aydin D; Bilici A; Yavuzer D; Kefeli U; Tan A; Ercelep O; Mert A; Yuksel S; Ozcelik M; Isik D; Surmeli H; Odabasi H; Aliustaoglu M
Clin Transl Oncol; 2015 Aug; 17(8):604-11. PubMed ID: 25786367
[TBL] [Abstract][Full Text] [Related]
28. CD44 rs13347 C>T polymorphism predicts breast cancer risk and prognosis in Chinese populations.
Jiang L; Deng J; Zhu X; Zheng J; You Y; Li N; Wu H; Lu J; Zhou Y
Breast Cancer Res; 2012 Jul; 14(4):R105. PubMed ID: 22788972
[TBL] [Abstract][Full Text] [Related]
29. Plasma microRNA-based signatures to predict 3-year postoperative recurrence risk for stage II and III gastric cancer.
Liu X; Zhang X; Zhang Z; Chang J; Wang Z; Wu Z; Wang C; Sun Z; Ge X; Geng R; Tang W; Dai C; Lin Y; Lin F; Sun M; Jia W; Xue W; Ji J; Hu Y; Qin G; Li J
Int J Cancer; 2017 Nov; 141(10):2093-2102. PubMed ID: 28722210
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-16 polymorphisms as new promising biomarkers for risk of gastric cancer.
Kashfi SM; Behboudi Farahbakhsh F; Nazemalhosseini Mojarad E; Mashayekhi K; Azimzadeh P; Romani S; Derakhshani S; Malekpour H; Asadzadeh Aghdaei H; Zali MR
Tumour Biol; 2016 Feb; 37(2):2119-26. PubMed ID: 26346169
[TBL] [Abstract][Full Text] [Related]
31. Regulation of CD44v6 expression in gastric carcinoma by the IL-6/STAT3 signaling pathway and its clinical significance.
Xu YY; Guo M; Yang LQ; Zhou F; Yu C; Wang A; Pang TH; Wu HY; Zou XP; Zhang WJ; Wang L; Xu GF; Huang Q
Oncotarget; 2017 Jul; 8(28):45848-45861. PubMed ID: 28507278
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
Guo J; Zu G; Zhou T; Xing J; Wang Z
Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
[TBL] [Abstract][Full Text] [Related]
33. CD44 gene polymorphisms in breast cancer risk and prognosis: a study in North Indian population.
Tulsyan S; Agarwal G; Lal P; Agrawal S; Mittal RD; Mittal B
PLoS One; 2013; 8(8):e71073. PubMed ID: 23940692
[TBL] [Abstract][Full Text] [Related]
34. Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival.
Tzanakis N; Gazouli M; Rallis G; Giannopoulos G; Papaconstantinou I; Theodoropoulos G; Pikoulis E; Tsigris C; Karakitsos P; Peros G; Nikiteas N
J Surg Oncol; 2006 Dec; 94(7):624-30. PubMed ID: 17111394
[TBL] [Abstract][Full Text] [Related]
35. The Expression of Melanoma-Associated Antigen D2 Both in Surgically Resected and Serum Samples Serves as Clinically Relevant Biomarker of Gastric Cancer Progression.
Kanda M; Nomoto S; Oya H; Takami H; Shimizu D; Hibino S; Hashimoto R; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S214-21. PubMed ID: 25743330
[TBL] [Abstract][Full Text] [Related]
36. The VEGFR-2 protein and the VEGFR-2 rs1870377 A>T genetic polymorphism are prognostic factors for gastric cancer.
Zhu X; Wang Y; Xue W; Wang R; Wang L; Zhu ML; Zheng L
Cancer Biol Ther; 2019; 20(4):497-504. PubMed ID: 30380970
[TBL] [Abstract][Full Text] [Related]
37. Ratio of CD44 epithelial variant to CD44 hematopoietic variant is a useful prognostic indicator in gastric and colorectal carcinoma.
Shibuya Y; Okabayashi T; Oda K; Tanaka N
Jpn J Clin Oncol; 1998 Oct; 28(10):609-14. PubMed ID: 9839501
[TBL] [Abstract][Full Text] [Related]
38. Topoisomerase IIβ binding protein 1 c.*229C>T (rs115160714) gene polymorphism and endometrial cancer risk.
Forma E; Wójcik-Krowiranda K; Jóźwiak P; Szymczyk A; Bieńkiewicz A; Bryś M; Krześlak A
Pathol Oncol Res; 2014 Jul; 20(3):597-602. PubMed ID: 24346708
[TBL] [Abstract][Full Text] [Related]
39. The correlations between DNA methylation and polymorphisms in the promoter region of the human telomerase reverse transcriptase (hTERT) gene with postoperative recurrence in patients with thyroid carcinoma (TC).
Li JJ; Zheng PCJ; Wang YZ
World J Surg Oncol; 2017 Jun; 15(1):114. PubMed ID: 28587656
[TBL] [Abstract][Full Text] [Related]
40. Combined epithelial-mesenchymal transition with cancer stem cell-like marker as predictors of recurrence after radical resection for gastric cancer.
Xu GF; Zhang WJ; Sun Q; Xu X; Zou X; Guan W
World J Surg Oncol; 2014 Dec; 12():368. PubMed ID: 25441488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
